Bernard Lam

690 total citations
14 papers, 121 citations indexed

About

Bernard Lam is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Bernard Lam has authored 14 papers receiving a total of 121 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 7 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Bernard Lam's work include Cancer Genomics and Diagnostics (8 papers), Genetic factors in colorectal cancer (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Bernard Lam is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), Genetic factors in colorectal cancer (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Bernard Lam collaborates with scholars based in Canada, United States and Ireland. Bernard Lam's co-authors include John S. Tam, C. Y. Yeung, Winnie W. S. Kum, Mun Hon Ng, Yousef Haj-Ahmad, Paul Haluska, Michael E. Menefee, Jinzhou Huang, Weitong Huang and Patricia LoRusso and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of Clinical Microbiology.

In The Last Decade

Bernard Lam

11 papers receiving 119 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernard Lam Canada 4 67 53 37 14 11 14 121
Jiangpeng Feng China 6 75 1.1× 26 0.5× 32 0.9× 35 2.5× 7 0.6× 11 149
Flora Donati France 8 54 0.8× 22 0.4× 83 2.2× 36 2.6× 6 0.5× 11 170
Wenjun Cai China 5 81 1.2× 18 0.3× 35 0.9× 16 1.1× 4 0.4× 9 166
Mircea Gabriel Stoleriu Germany 5 121 1.8× 13 0.2× 44 1.2× 9 0.6× 6 0.5× 15 200
Naoya Ichimura Japan 8 60 0.9× 12 0.2× 49 1.3× 13 0.9× 20 1.8× 14 168
Leonardo Mina Spain 5 113 1.7× 16 0.3× 13 0.4× 33 2.4× 29 2.6× 12 178
André M. Ribeiro-dos-Santos Brazil 8 87 1.3× 27 0.5× 34 0.9× 14 1.0× 4 0.4× 18 154
Krishnan Harinivas Harshan India 8 76 1.1× 15 0.3× 100 2.7× 33 2.4× 4 0.4× 20 201
Cho‐Chin Cheng Germany 6 77 1.1× 10 0.2× 73 2.0× 11 0.8× 4 0.4× 8 148

Countries citing papers authored by Bernard Lam

Since Specialization
Citations

This map shows the geographic impact of Bernard Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Lam more than expected).

Fields of papers citing papers by Bernard Lam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Lam. The network helps show where Bernard Lam may publish in the future.

Co-authorship network of co-authors of Bernard Lam

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard Lam. A scholar is included among the top collaborators of Bernard Lam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard Lam. Bernard Lam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Luo, Ping, Derek Wong, Leslie E. Oldfield, et al.. (2025). O10: Early detection of BRCA1/2-associated cancers through multi-modal cell-free DNA analysis. Genetics in Medicine Open. 3. 102035–102035.
2.
Dhani, Neesha C., Wang Li, Robert C. Grant, et al.. (2024). 763P Re-VOLVE: Phase II trial in women with ovarian cancer progressing post-PARP-inhibitor with treatment adapted to real-time assessment of evolving genomic resistance. Annals of Oncology. 35. S577–S578. 1 indexed citations
3.
4.
Kain, Dylan, Sandra Isabel, Richard de Borja, et al.. (2023). Coronavirus disease 2019 (COVID-19) outbreak on an in-patient medical unit associated with unrecognized exposures in common areas—Epidemiological and whole-genome sequencing investigation. Infection Control and Hospital Epidemiology. 44(11). 1829–1833. 1 indexed citations
5.
Beaudry, Felix E.G., Savo Lazic, Faridah Mbabaali, et al.. (2023). 1. Clinical validation of plasma whole genome sequencing for detection of minimal residual disease from solid tumours. Cancer Genetics. 278-279. 1–1. 1 indexed citations
6.
7.
Stutheit-Zhao, Eric Y., Zhihui Liu, Kayla Marsh, et al.. (2022). Methylated circulating tumor DNA (cfMeDIP) as a predictive biomarker of clinical outcome in pan-cancer patients (pts) treated with pembrolizumab (P).. Journal of Clinical Oncology. 40(16_suppl). 2550–2550. 5 indexed citations
8.
Zhang, Amy, Robert E. Denroche, Bernard Lam, et al.. (2021). Whole-genome sequencing of cholangiocarcinoma to reveal distinct profiles of patients with underlying cirrhosis or inflammatory disorders.. Journal of Clinical Oncology. 39(3_suppl). 340–340. 1 indexed citations
9.
Jang, Gun Ho, Amy Zhang, Robert E. Denroche, et al.. (2021). Impact of KRAS mutational status on outcomes in patients with pancreatic cancer (PDAC).. Journal of Clinical Oncology. 39(15_suppl). 4142–4142. 1 indexed citations
10.
Jang, Gun Ho, Amy Zhang, Robert E. Denroche, et al.. (2021). hENT1 gene expression as a predictor of response to gemcitabine and nab-paclitaxel in advanced pancreatic cancer.. Journal of Clinical Oncology. 39(15_suppl). 4011–4011. 2 indexed citations
11.
O’Kane, Grainne M., Gun Ho Jang, Amy Zhang, et al.. (2020). Outcomes and Immunogenicity of pancreatic cancer stratified by the HRDetect score.. Journal of Clinical Oncology. 38(15_suppl). 4630–4630. 3 indexed citations
12.
Lam, Bernard, et al.. (2018). Diversity and signature of small RNA in different bodily fluids using next generation sequencing. BMC Genomics. 19(1). 408–408. 65 indexed citations
13.
Haluska, Paul, Jinzhou Huang, Bernard Lam, et al.. (2011). MEDI-573 as a novel approach to IGF-1R and IR-A signaling inhibition by blocking IGF ligands: Phase I PK/PD, safety data, and disease linkage studies in breast cancer.. Journal of Clinical Oncology. 29(27_suppl). 271–271. 5 indexed citations
14.
Tam, John S., Winnie W. S. Kum, Bernard Lam, C. Y. Yeung, & Mun Hon Ng. (1986). Molecular epidemiology of human rotavirus infection in children in Hong Kong. Journal of Clinical Microbiology. 23(3). 660–664. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiangpeng Feng Breakdown of academic impact, for papers by Flora Donati Breakdown of academic impact, for papers by Wenjun Cai Breakdown of academic impact, for papers by Mircea Gabriel Stoleriu Breakdown of academic impact, for papers by Naoya Ichimura Breakdown of academic impact, for papers by Leonardo Mina Breakdown of academic impact, for papers by André M. Ribeiro-dos-Santos Breakdown of academic impact, for papers by Krishnan Harinivas Harshan Breakdown of academic impact, for papers by Cho‐Chin Cheng
Rankless by CCL
2026